Brought to you by 
Arris acquires Sequana Therapeutics in a $166mm stock swap
15 Jul 1999
Executive Summary
In a $166mm stock swap, drug discovery company Arris acquired genomics-based Sequana. Arris will issue Sequana stockholders 1.35 shares of its common stock for each Sequana share, or about $16.20 apiece, based on its own $12 trading price.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Arris acquires Sequana Therapeutics in a $166mm stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice